首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1345386

全球子宮操縱器械市場 - 2023-2030

Global Uterine Manipulation Devices Market - 2023-2030

出版日期: 2023年09月06日 | 出版商:

DataM Intelligence | 英文 195 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球子宮操縱器械市場在 2022 年達到 2.704 億美元，預計到 2030 年將達到 4.251 億美元，2023-2030 年預測期間年複合成長率為 5.9%。

預計推動全球子宮操縱設備市場成長的主要因素包括與女性生殖系統相關的疾病日益增多、技術進步不斷成長以及對微創手術方法的需求不斷成長。與女性生殖系統相關的典型疾病包括宮頸癌、子宮肌瘤、子宮內膜異位症、多囊卵巢症候群和間質性細胞增多症等。

根據世界衛生組織的數據，2022 年2 月，宮頸癌是全球女性中第四大典型癌症，評估了604,000 名新近患者，2020 年有超過342,000 人死亡。2020 年全球新發病例和死亡人數中約90% 是在2020 年出現的。低收入和中等收入國家。據評估，HPV 感染每年導致 530 000 例宮頸癌病例和超過 264 000 例宮頸癌死亡。

子宮操縱器的混合設計旨在提高腹腔鏡女性生殖系統手術過程中的手術性能，包括麥卡特尼陰道管。常用的子宮操縱裝置包括海綿棒、EEA sizer、ZUMI/HUMI 和 K-UMI 裝置、Advincula Arch、RUMI II 系統、ClearView、Advincula Delineator 和 V-Care 以及市場上現有或正在開發的其他裝置。

市場動態

婦科疾病病例不斷增加

與女性生殖系統相關的典型疾病包括宮頸癌、子宮肌瘤、子宮內膜異位症、多囊卵巢症候群和間質性細胞增多症等。預計上述疾病病例的增加將在預測期內推動全球市場的成長。例如，根據國家癌症登記計劃，乳腺癌和宮頸癌是女性中診斷出的非常典型的癌症。在印度女性中，宮頸癌佔所有癌症的 6-29%。

此外，根據世界衛生組織的數據，子宮內膜異位症影響著全世界大約 10%（1.9 億）的育齡婦女和女孩。此外，多囊卵巢綜合症是一個重大的公共衛生問題，也是影響育齡女性的最常見的荷爾蒙失調症之一。據估計，這種疾病影響了 8-13% 的育齡女性，並且大約 70% 的患者未被診斷出來。

此外，根據2021年9月至2022年2月在中國南京南京醫科大學附屬醫院進行的一項橫斷面研究，樣本量為977名18-52歲的女性。最主要的婦科疾病是痛經，佔45.96%，其次是多囊卵巢症候群，多囊卵巢綜合症，佔19.04%，子宮肌瘤，佔14.23%，自然流產，佔13.20%，不孕不育，佔12.59%，卵巢功能障礙佔11.16%，子宮內膜異位症佔4.09%。

增加女性健康舉措

提高認知和支持女性生殖健康的舉措不斷增加，也推動了預測期內全球市場的成長。例如，2022 年3 月，致力於提高認知、促進教育和支持子宮內膜異位症研究的非營利組織美國子宮內膜異位症基金會舉辦了幾個週末的虛擬活動來紀念患者日，包括腹膜子宮內膜異位症和疼痛以及更嚴重的衰弱狀況及其最終治療。這種媒介的開發是為了幫助個人與他人聯繫、了解他們的狀況並分享他們的自我經歷。

此外，FDA 婦女健康辦公室與 NIH 婦女健康研究辦公室合作，提高對參與臨床試驗的不同年齡、種族、民族背景和健康必需品的各種女性的認知。此外，消除宮頸癌的預防和篩查創新項目(PRESCRIP-TEC) 是一個為期三年的項目，從2021 年2 月到2024 年1 月，其研究重點是提高資源貧乏或難以獲得宮頸癌診斷的地區的採用率。到達孟加拉國、印度、烏干達和斯洛伐克的環境。

不斷成長的研究活動

提高子宮操縱器在不同子宮手術中的安全性的研究活動不斷增加，正在推動全球市場的成長。例如，2022 年1 月，“獲得性子宮肌層假性動脈瘤的超聲成像：腹腔鏡手術期間機械手作為異常原因的作用”的調查表明，尖端7 厘米的ClearView 子宮機械手在婦科手術中的結果得到了批准，表明它們在婦科手術中是安全的在外科手術期間使用。

此外，2023 年6 月，來自Jaume I 大學生物力學和人體工程學研究機構的Asociacion RUVID 研究人員、卡斯特羅綜合大學醫院腹部盆腔腫瘤手術轉介科(UR-COAP) 和Fisabio 基金會設計了一種用於微創婦科手術的無創傷子宮操縱器。經過評估可以避免對初始腫瘤的傷害，降低操作子宮造成的傷害，並減少潛在致癌物的潛在遷移。

使用不當引起的併發症

儘管子宮操縱器提供了諸多好處，但使用子宮操縱器並非沒有危險。操縱器的不當使用或放置可能會對子宮或周圍組織造成損害，並可能導致出血或感染等複雜情況。如果腹腔鏡子宮操縱器放置不準確或操縱時施加的壓力過大，則有子宮穿孔的可能。這可能會導致出血或鄰近器官損傷。

此外，如果腹腔鏡子宮操縱器在使用前未正確消毒，則存在現場感染的危險。這可能導致術後感染，可能需要進一步治療。使用腹腔鏡子宮操縱器操縱子宮可能會引起出血，特別是在存在肌瘤或其他子宮異常的情況下。通過將適當的應用操縱器插入直接骨盆可視化下方的子宮中，可以避免這些複雜的情況。

缺乏外科專家

婦產科醫生的供需差距不斷擴大預計將減緩預測期內的市場成長。例如，根據《March of Dimes》的數據，超過 220 萬美國育齡女性生活在“產婦護理沙漠”中，其中約 690 萬身材矮小或無法獲得婦科醫療保健。美國有一半的國家沒有任何婦產科 (OB/GYN) 機構。

此外，美國衛生與公眾服務部預計 2021 年婦產科醫生數量將從 50,850 人減少至 47,490 人（7%），但到 2030 年需求預計將從 50,850 人增加至 52,660 人（4%）。此外，美國醫學院協會(AAMC) 估計，到2032 年，醫生短缺量約為122,000 名，婦產科也不例外。美國醫學院協會 2023 年的初步數據顯示，每個婦產科住院醫師項目的申請數量從 2022 年的 663 人下降到 2023 年的 650 人。

Market Overview

Global Uterine Manipulation Devices Market reached US$ 270.4 million in 2022 and is expected to reach US$ 425.1 million by 2030, growing with a CAGR of 5.9% during the forecast period 2023-2030.

The primary factors expected to boost the global uterine manipulation devices market include the growing disorders associated with the female reproductive system, rising technological advancements, and growing demand for minimally invasive surgical approaches. Typical disorders associated with the female reproductive system includes cervical cancer, uterine fibroids, endometriosis, polycystic ovary syndrome, and interstitial cytosis, among others.

According to World Health Organization, in February 2022, cervical cancer was the fourth highly typical cancer diagnosed in females globally, with an assesed 604,000 recent patients and over 342,000 deaths in 2020. Approximately 90% of the recent cases and deaths worldwide in 2020 surfaced in low- and middle-income nations. The HPV infection is accountable for an assessed 530 000 cases of cervical cancer and over 264 000 cervical cancer deaths annually.

A mixture of uterine manipulators has been designed to enhance surgical performance during laparoscopic female reproductive system surgical procedures, including the McCartney vaginal tube. The commonly utilized uterine manipulation devices include sponge stick, EEA sizer, ZUMI/HUMI, and K-UMI devices, Advincula Arch, The RUMI II System, ClearView, Advincula Delineator, and V-Care, among others available on the market or under development.

Market Dynamics

Growing Cases of Gynecological Disorders

Typical disorders associated with the female reproductive system include cervical cancer, uterine fibroids, endometriosis, polycystic ovary syndrome, and interstitial cytosis, among others. The growing cases of the abovementioned disorders are expected to drive global market growth during the forecast period. For instance, according to the National Cancer Registry Programme, the cancer of breast and cervix uteri was the highly typical cancer diagnosed in females. Cervical cancer makes up for 6-29% of all cancers among females in India.

Also, according to the WHO, Endometriosis impacts approximately 10% (190 million) of reproductive-age women and girls worldwide. Moreover, PCOS is a significant public health problem and is among the most commonly diagnosed hormonal disorders impacting females of reproductive age. The disorder impacts an assessed 8-13% of females of reproductive age, and around 70% of patients are undiagnosed.

Moreover, according to a cross-sectional study conducted at a hospital affiliated with Nanjing medical university in Nanjing, China between September 2021 and February 2022, with a sample size of 977 women aged 18-52 years. The highly predominant gynecological condition was dysmenorrhea with 45.96% of cases, heeded by polycystic ovary syndrome, PCOS accounting for 19.04% of cases, uterine fibroids with 14.23% of cases, spontaneous abortion with 13.20% of cases, 12.59% cases of trouble conceiving, ovarian dysfunction accounting for 11.16% cases and endometriosis accounting for 4.09% of cases.

Increasing Female Health Initiatives

The increasing initiatives to promote awareness and support female reproduction health also drive the global market growth during the forecast period. For instance, in March 2022, the Endometriosis Foundation of America, Inc., a non-profit organization committed to increasing awareness, boosting education, and supporting endometriosis research hosted several weekends of virtual events to mark Patient Day, including peritoneal endometriosis and pain and more serious debilitating condition and its conclusive therapy. This medium is developed to assist individuals to join with others, understand their condition, and share their self-experiences.

Moreover, the FDA Office of Women's Health partnered with the NIH Office of Research on Women's Health to increase awareness regarding various females of distinct ages, races, ethnic backgrounds, and health necessities partaking in clinical trials. Further, the Prevention and Screening Innovation Project Toward Elimination of Cervical Cancer (PRESCRIP-TEC), a three-year project from February 2021 - January 2024 concentrates its investigation on improving the adoption of cervical cancer diagnoses in resource-poor or hard-to-reach environments of Bangladesh, India, Uganda and Slovakia.

Growing Research Activities

The increasing research activities to increase the saftey of uterine manipulators in distinct uterine sugeries are boosting the global market growth. For instance, in January 2022, the investigation "Ultrasound Imaging of Acquired Myometrial Pseudoaneurysm: The Role of Manipulators as an Unusual Cause during Laparoscopic Surgery" demonstrated approving outcomes for ClearView Uterine Manipulator, 7 cm tip in gynecological surgery, exhibiting that they are secure to be utilized during surgical operations.

Moreover, in June 2023, the Asociacion RUVID Researchers from the Biomechanics and Ergonomics research body of the Universitat Jaume I, the Abdomino-Pelvic Oncology Surgery Referral Unit (UR-COAP) of the General University Hospital of Castello and the Fisabio Foundation have designed an atraumatic uterine manipulator for minimally invasive gynecological procedures. Assessed to avert injury to the initial tumor, lower the harm done by manipulating the uterus and decrease the potential migration of potential carcinogens.

Complications Induced by Inapropriate Use

Despite the benefits offered by uterine manipulators, the use of uterine manipulators is not without hazards. Inappropriate usage or placement of the manipulator can provoke damage to the uterus or encompassing tissues and may direct intricacies like bleeding or infection. There is a chance of uterine perforation in the case if laparoscopic uterine manipulator is not placed accurately or too extensive pressure is applied during manipulation. This can guide to bleeding or damage to adjacent organs.

Also, there is a peril of infection at the site if the laparoscopic uterine manipulator is not sterilized properly prior to use. This can lead to postoperative infection, which may need further treatment. The manipulation of the uterus with the laparoscopic uterine manipulator can induce bleeding, particularly if there are fibroids or other uterine anomalies present. These sorts of intricacies can be averted by the appropriate application manipulator into the uterus underneath immediate pelvic visualization.

Lack of Surgical Specialists

The increasing gap in the demand and supply of Obstetricians and Gynecologists is expected to slow the market growth in the forecast period. For instance, according to the March of Dimes, over 2.2 million U.S. females of childbearing age living in "maternity care deserts," and around 6.9 million have undersized or no access to gynecological healthcare. Half of the nations in the United States do not have any obstetrics and gynecology (OB/GYN) establsihments.

Moreover, the U.S. Department of Health and Human Services in 2021, estimated that the number of OB-GYNs to drop from 50,850 to 47,490 (7%), however the need is estimated to grow from 50,850 to 52,660 (4%) by 2030. Further, the Association of American Medical Colleges (AAMC) estimated a shortage of around 122,000 medics by 2032, and OB/GYN is no anomaly. The initial 2023 data from the American Association of Medical Colleges discloses that the moderate number of applications per obstetrics and gynecology residence program dropped from 663 in 2022 to 650 in 2023.

Segment Analysis

The global uterine manipulation devices market is segmented based on product type, type, application, end-user and region.

Increasing Number of Hysterectomy Procedures Conducted

Hysterectomy is surgery to extract the uterus/womb, out of the procedures specific to females, hysterectomies are the second most performed surgery in the U.S. (after cesarean sections). NIH, estimations indicate that one out of nine females will experience a hysterectomy in their lifetime and that roughly 600,000 operations are conducted annually in the United States. Moreover, according to NIH, in India, the preponderance of hysterectomy procedures was 3.2%, the highest in Andhra Pradesh (8.9%) and the lower in Assam (0.9%). Rural India had elevated a preponderance than urban India.

Further, one out of three women in the U.S. have had a hysterectomy by age 60. Therefore, the growing female geriatric population will also contribute to the segment growth in the forecast period. For instance, according to the National Statistical Office (NSO)'s Elderly in India 2021 report, India's geriatric residents (aged 60 and above) were estimated to brush 194 million in 2031 from 138 million in 2021, a 41 percent growth over a decade.

Geographical Penetration

North America Accounted for Approximately 37.1% of the Market Share in 2022 Owing to the Growing Cases of Gynecological Disorders

The growing demand for gynecological surgeries owing to increasing cases of gynecological disorders in this region. For instance, according to the American Cancer Society's 2023, estimations around 13,960 fresh cases of invasive cervical cancer are expected to be diagnosed and, over 4,310 females are expected to die from cervical cancer by the end of 2023. Moreover, according to the US Department of Health and Human Services, Endometriosis is estimated to affect over 11% of American females between 15 and 44. It is extremely typical among females in their 30s and 40s and may cause it more difficult to acquire pregnancy.

Moreover, according to CDC, PCOS is among the highly typical reasons for female infertility, impacting 6% to 12%, accounting for around 5 million US females of reproductive age. Interstitial cystitis (IC) is highly typical, the disorder is estimated to impact 3 million to 8 million women and between 1 million to 4 million men in the United States. Further, the Centers for Disease and Prevention (CDC) reports that roughly 600,000 hysterectomies are conducted in the United States annually.

Similarly, according to Behavioral Risk Factor Surveillance System (BRFSS) or the National Health Interview Survey (NHIS), analysis of growing trends in hysterectomy prevalence by age and directional differences by race and ethnicity were observed with less than 2% of women aged 20-29 years and over 4 in 10 females aged 70-79 years documented undergoing hysterectomy. Furthermore, the increasing initiatives and availability of reimbursement policies in the United States ensures the North America's uterine manipulation devices market growth in the forecast period.

For instance, the Medicare covers a doctor considered medically necessary hysterectomy. Again, the U.S. Preventive Services Task Force (USPSTF) suggests screening for cervical cancer every 3 years with a Pap test in females aged 21 to 29 years, and for women ages 30 to 65 years, a Pap test screening every 3 years with high-risk human papillomavirus (hrHPV) testing every 5 years, or every 5 years with both types of tests. Again, the NCI Cervical Cancer 'Last Mile' Initiative, a public-private collaboration getting together federal agencies, industry associates, and professional associations to contribute proof regarding the precision and clinical significance of self-sampling-based HPV testing for cervical cancer screening.

Competitive Landscape

The major global players in the market include CooperSurgical Inc., MEDGYN PRODUCTS, INC., CONMED Corporation, Peters Surgical., Zhejiang Geyi Medical Instrument Co.,Ltd, Laborie, HTKD Medical, Bissinger Medizintechnik, Purple Surgical, Ningbo Xinwell Medical Technology Co., LTD., Utah Medical Products, Inc., and Panpac Medical Corp. among others.

COVID-19 Impact Analysis

According to an article titled, "Gynecological Surgery and COVID-19" published in July 2020, an estimated 28 million procedures were delayed or withdrawn globally because of the pandemic, forcing a hold on the diagnosis and treatment of over 2 million cancer patients. In Brazil, both the National Health Agency (ANS) and National Health Surveillance Agency (ANVISA) advised the postponement of elective and non-essential procedures, caused a significant impact on the number of surgical procedures that decreased by 33.4% in this period.

Moreover, according to a nationwide survey by the Japan Society of Obstetrics and Gynecology, the whole number of surgeries dropped from 129,648 in 2019 to 118,565 in 2020, accounting for 8.5%, for all surgical operations. Nevertheless, there was steep growth in the number of robotic procedures conducted in 2020 corresponded to that in 2019 for all inhabitants. The number of entire hysterectomies declined markedly from 15,385 in 2019 to 12,531 in 2020, a demonstrating a drop of 10.1%.

Again, earlier during the pandemic, ambulatory visitings at some medical centers in the U.S. dropped significantly, with a concurrent growth in telehealth visits. Yet, the transformation of in-person care to telemedicine care was inconsistent across experties. Procedure volumes were even dropped throughout the multiple specialties.

Surprisingly, actually volumes for some sorts of emergency department care were attenuated, including for some gynecologic disorders. COVID-19 has altered clinical and surgical approaches in benign gynecology. It has directed medics to begin employing telemedicine for gynecologic care more readily, and considerable gynecologists have continued to employ this approach of health care even when the pandemic has subsided.

By Product Type

Tintara Type
Hohl Type
Donnez Type
Advincula Arch Type
Others

By Type

Single-Use
Multi-Use

By Application

Hysterectomy

Partial Hysterectomy

Total Hysterectomy

Radical Hysterectomy

Laparoscopic Ovarian Cystectomy
Myomectomy
Others

By End-User

Hospitals
Gynecological Clinics
Ambulatory Surgical Canters
Academic & Research Centers
Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

Middle East and Africa

Key Developments

In October 2021, Laborie Medical Technologies Corp. (Laborie), a specialist medical technology corporation, acquired Pe lvalon, Inc., a privately owned medical device corporation established in Redwood City, CA.
In September 2021, Boston Scientific Corporation, a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices, completed the acquisition of Devoro Medical, a privately held corporation. Devoro Medical specializes in designing minimally invasive devices for abnormal uterine bleeding.
In February 2021, CooperSurgical Inc., a market leader in the designing, manufacturing, and commercialization of medical devices utilized to advance women's healthcare and minimally invasive surgery completed the acquisition of AEGEA Medical. The acquisition was expected to allow the corporation to expand its women's healthcare product line.

Why Purchase the Report?

To visualize the global uterine manipulation devices market segmentation based on product type, type, application, end-users and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of uterine manipulation devices market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key product of all the major players.

The global uterine manipulation devices market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Type
3.3. Snippet by Application
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Cases of Gynecological Disorders
  - 4.1.1.2. Increasing Female Health Initiatives
  - 4.1.1.3. Growing Research Activities
- 4.1.2. Restraints
  - 4.1.2.1. Complications Induced
  - 4.1.2.2. Lack of Surgical Specialists
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. Distribution Channel Trend
5.7. SWOT Analysis
5.8. Russia-Ukraine War Impact Analysis
5.9. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Tintara Type*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Hohl Type
7.4. Donnez Type
7.5. Advincula Arch Type
7.6. Others

8. By Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 8.1.2. Market Attractiveness Index, By Type
8.2. Single-Use*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Multi-Use

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Hysterectomy*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 9.2.3. Partial Hysterectomy
- 9.2.4. Total Hysterectomy
- 9.2.5. Radical Hysterectomy
9.3. Laparoscopic Ovarian Cystectomy
9.4. Myomectomy
9.5. Others

10. By End-User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 10.2.3. Gynecological Clinics
- 10.2.4. Ambulatory Surgical Canters
- 10.2.5. Academic & Research Centers
- 10.2.6. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. UK
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. CooperSurgical Inc.*
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. MEDGYN PRODUCTS, INC.
13.3. CONMED Corporation
13.4. Peters Surgical.
13.5. Zhejiang Geyi Medical Instrument Co.,Ltd
13.6. Laborie
13.7. HTKD Medical
13.8. Bissinger Medizintechnik
13.9. Purple Surgical
13.10. Ningbo Xinwell Medical Technology Co., LTD.
13.11. Utah Medical Products, Inc.
13.12. Panpac Medical Corp.